Estée Lauder Invests in 111Skin

Estée Lauder Invests in 111Skin
The Estée Lauder Companies has acquired a minority stake in 111Skin, a luxury clinical skincare brand founded in 2012 by plastic surgeon Dr. Yannis Alexandrides. This strategic investment reflects the beauty conglomerate's commitment to science-backed formulations and treatment-led innovation in the competitive skincare market. Originally developed to accelerate healing following surgical procedures, 111Skin has evolved into a premium brand serving consumers worldwide seeking professional-grade skincare solutions. The partnership positions Estée Lauder to capitalize on growing consumer demand for dermatologically-tested products that deliver measurable results. By acquiring a stake in 111Skin, Estée Lauder gains access to cutting-edge skincare technology and a brand with strong credentials in clinical efficacy.